−0.06 USD
−3.17 M USD
608.52 K USD
19.02 M
About Nuo Therapeutics, Inc.
Sector
Industry
CEO
David Emerson Jorden
Website
Headquarters
Houston
Founded
1998
FIGI
BBG00FS7XGP1
Nuo Therapeutics, Inc. engages in the development and sale of biomedical products for chronic wound care. It offers Aurix point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Houston, TX.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AURX is 1.15 USD — it has increased by 27.78% in the past 24 hours. Watch Nuo Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nuo Therapeutics, Inc. stocks are traded under the ticker AURX.
AURX stock has risen by 41.98% compared to the previous week, the month change is a 85.01% rise, over the last year Nuo Therapeutics, Inc. has showed a 119.01% increase.
AURX reached its all-time high on Oct 5, 2022 with the price of 4.50 USD, and its all-time low was 0.0001 USD and was reached on Dec 27, 2021. View more price dynamics on AURX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AURX stock is 25.14% volatile and has beta coefficient of 0.20. Track Nuo Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nuo Therapeutics, Inc. there?
Today Nuo Therapeutics, Inc. has the market capitalization of 41.94 M, it has increased by 26.76% over the last week.
Yes, you can track Nuo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
AURX net income for the last quarter is −578.17 K USD, while the quarter before that showed −540.09 K USD of net income which accounts for −7.05% change. Track more Nuo Therapeutics, Inc. financial stats to get the full picture.
No, AURX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 9.00 employees. See our rating of the largest employees — is Nuo Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nuo Therapeutics, Inc. EBITDA is −2.39 M USD, and current EBITDA margin is −503.35%. See more stats in Nuo Therapeutics, Inc. financial statements.
Like other stocks, AURX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuo Therapeutics, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuo Therapeutics, Inc. stock shows the buy signal. See more of Nuo Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.